chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the vaccine on the 23rd of October and by the end of the month I was feeling stiffness in the wrist. I couldn?t fully flex it and it was really sore. The soreness would go up my arm and courting in my inner elbow. Over the course of the first month, I felt this stiffness in my wrist, into elbow and arm. And I was also getting swelling on my forearm and eventually watch would not go around arm. I lost mobility and flexibility in that arm. I do activities all the time and I never remember injuring myself during these activities. After 2 months, it wasn?t getting any better but not getting too worse. Still painful, swelling, immobility. Went to PCP early December. She couldn?t figure it out. I have had a left side mastectomy in 1995. Removed 20+ lymph nodes so I get everything done on the right side for blood pressure, vaccines, etc. PCP ordered an ultrasound of my left axillary. Ordered a vascular ultrasound to rule out blood clots. She figured it was lymph edema kicking in as an immune response and sent me to Physical Therapist who specializes in that. So we ruled out everything, and PT said it was low lymph edema swelling and a lymph edema response. Some people will get lymph nodes responses when they don?t have lymph nodes on the other side. Her colleagues have noted that they have also seen this in clients who don?t have lymph nodes. I?ve seen PT 3 times now, and I wear a compression sleeve. PT thinks it will resolve and the immune response will eventually settle down. I do physical exercises and massage lymph nodes areas to move around to other active areas. Still pain, heaviness, swelling, but doing better. PT thinks this will resolve in the next few months. Only been having PT for the month of January so far. Never had lymph edema problems until this health event.
Patient complains of Tachycardia and dizziness. Patient having Panic attack from taking vaccine.  Patient was observed for 30 mins,  and  did not have any other adverse reaction. V/S stable , respiration even and unlabored, no apparent distress noted.  Patient felt better, and no further treatment needed.  Starting BP: 176/94, HR 120, ), O2 sat: 100% Ending Vitals: BP: 145/88, HR: 100, O2 sat : 100%
Isolated tachycardia up to 140s-150s approximately 24 hours after vaccination. No chest pain or discomfort, shortness of breath, or fever.
About 30 minutes after receiving vaccination, patient started to have tingling and mild swelling in her lips as well as tachycardia. Vital signs taken.  Heart rate was 102 bpm, respiratory rate 18, blood pressure 144/80, O2 Sat 98%.   Received cetirizine 10 mg PO.  Symptoms resolved within one hour of receiving cetirizine.
After getting the vaccine, I had three unpredictable menstruation cycles in one month. This is not common for me, nor have I ever had more than one period in one month.
Severe pain in deltoid region (at the site of injection) began within 2 hours of vaccination.  Pain has continued for more than a month with little improvement and consistent worsening. Swelling and pain at more than a month.
After approximately 15 min observation the person became faint when standing and was caught by medical personnel to prevent fall and potential injury. No Shortness of breath Chest and airway were clear .  Complained of numbness and tingling of the face Pulse > 100  Blood Pressures were 155/93 ( patient stated that the readings exceeded her normal blood pressures which are typically 110 / 70 -120/80
I felt really good until late at night when I got a pretty mild headache, then I started shivering and I didn't stop for nearly an hour. My muscles were very tense and the headache got worse. I took ibuprophen and that seemed to help with the shivering and lessen the headache. It is now the morning after and I just have a mild, but persistent headache and skin sensitivity which I don't know if it's related to getting the vaccine or not.
PATIENT BROKE OUT IN RASH ONE DAY AFTER HIS SECOND SHOT. HIS TRUNK, ARMS AND LEGS ARE COVERED IN HIVES.
A public health client is complaining that her provider mixed Td and PNV23 vaccines in the same syringe and administered them together in her arm. She developed inflammation at the injection site that lingered for 2 weeks. Pt went to the emergency room the evening of the immunization with fever and vomiting and was hospitalized.  No mention of the immunization was in the medical records.  She was diagnosed with sepsis.
still has issues trying to normalize the menstruation; This is Spontaneous report received from a contactable consumer (patient). This consumer reported similar events for 2 patients (mother and daughter). This is a mother case.  An unknown age female patient received BNT162B2 on Mar2021 at single dose for COVID-19 immunisation. Medical history and concomitant drug were not reported. Patient experienced menstrual irregularities as a reported adverse event after getting the Pfizer BioNtech Covid-19 Vaccine. Outcome of the event was unknown.  This lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101169504 same drug and AE, different patient
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # L035836, expiration date 19-AUG-2017 (exact dose was not reported, orally). There was no adverse effect reported. Administered doses experienced the temperature excursion of 48.7 degrees Fahrenheit for 24 hours. There was no previous temperature excursions. A data logger was involved. This is one of two reports received from the same reporter. Additional information has been requested.
Got flu shot 11/12/02. Had subsequent tremendous nasal congestion to point of creating inability to breathe through nose started Prednisone taper.
Patient first noticed red welt size of quarter at injection site on Sunday 06/10/07, about 2 pm, it spread rapidly after that to become a large hot, red welt extending around mid upper left arm. Patient treated with Prednisone 20mg, 2 PO qd x 4 days and Keflex 250mg QID x 7 days on 06/12/07.
Administration of Menquadfi post excursion with no reported adverse event; Initial information received on 10-Mar-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 13 years old female patient who was administered meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] post excursion with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s) and family history were not provided.   On 13-Dec-2022, the patient received 0.5 mL  dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, Solution for injection (frequency- once (1x), lot U7449AB, expiry date - 23-Sep-2024, strength - unknown) via intramuscular route in unknown administration site for immunization post excursion with no reported adverse event (poor quality product administered) (Latency: same day).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA082363:linked report US-SA-2023SA082367:linked report US-SA-2023SA081681:linked report US-SA-2023SA082373:linked report US-SA-2023SA082416:linked report US-SA-2023SA082953:linked report US-SA-2023SA082382:linked report US-SA-2023SA082675:linked report US-SA-2023SA082418:linked report US-SA-2023SA082418:linked report
The patient is a 52 yo female w/ history of moderately differentiated squamous cell carcinoma of the base of the left tongue, clinical stage III, status post tracheostomy emergent in November 2015 for a rapidly enlarging epiglottic mass . She was treated with combined modality cisplatin and radiation therapy from 12/30/15 ­ 2/23/16. One month later, she had noted increased left cervical pain and with a positive PET­CT affirmation in April 2016. She had disease recurrence with the tongue only. She then received Erbitux from May 19, 2016 until February 24, 2017. There was no lesion on a direct visualization with a laryngoscopy performed by ENT. She has been followed by observation since 2/2017.  She has moved to another hospital and was referred to me to establish care. Her tracheostomy was removed in July 2017, she has associated chronic pain of her left necko, for which she is being treated by the pain clinic. She has a chemical dependency history, now abstinent. She is status p st left nephrectomy in year 2000 and a self­reported history of melanoma with no clinical data available to confirm this.  She follows with doctor every 6 months and last saw him in October 2021 and was continued on observation.  She follows a different doctor and is on bupinorphine and gabapentin. Patient presented to the ER on 2/2 w/ complaints of SOB and strider.  She tested positive for COVID.  CXR looked ok.  Labs also unrevealing.  She was given a dose of IV decadron and admitted for further eval. PT IS INPATIENT AT THIS TIME.
On 02/21/2001 the patient experienced shingles on his right thigh. The patient had no history of clinical varicella. The patient fully recovered. A herpes zoster questionnarie indicated that on 02/27/02 the herpes zoster broke out right L3 distrubution, the duration was about 10 days on oral Acyclovir.Normal temperature pain rated a 7. There was no history of chicken pox. A photo was included.
Patient's wife called pharmacy, her husband is a truck driver, got the first SHINGRIX shot and was getting the second with an annual flu shot. Per her report pt started feeling flu like symptoms about 4 hours after the shot. These symptoms grew to be quite severe cramping, nausea, headache, chills, sweats, to the point where he thought to maybe go to ER. He continued to wait in his hotel room and the following morning was not 100% better but was feeling better than the night before and would not seek treatment from ER.
The night of my second dose I developed, what felt like, heartburn. Neither Tums nor food relieved the pain. Pain lasted about 5 days. On the fifth day, heartburn-like pain subsided and a moderate headache developed. Eyes also felt very hot and continue to to this day.
Telephone call from patient.  Complaint of left arm discomfort with administration of influenza vaccine. Experienced increasing soreness. Was painful to rest on left side that evening following vaccination.  Not red, swollen, or feverish.  States arm has continued to be sore, particularly in joint.  Has normal strength, but uncomofrtable to raise left arm overhead.  Patient to see her private MD on 111-22-04 for routine exam.  Plans to ask him to evaluate.
This case was reported by a pharmacist via call center representative and described the occurrence of skin discoloration in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced skin discoloration and leg infection. On an unknown date, the outcome of the skin discoloration and leg infection were unknown. It was unknown if the reporter considered the skin discoloration and leg infection to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist states that the patient got their dose of SHINGRIX and said recently after receiving SHINGRIX he developed discoloration on their lower leg and the leg became infected. The HCP could not remember the patient's name or demographic information since the initial reason for his call was to ask about timing of SHINGRIX vaccine in patients receiving steroid injection. The HCP mentioned 3 separate patients with rare side effects these patients were complaining about after receiving SHINGRIX but the HCP did not remember these patients names or demographic information the 3 separate Adverse events for three separate patients reported for this one HCP. This case linked with US2019015732 and US2019015728, reported by same reporter.
Headache, chills, red hard area at injection site measuring 3-4" diameter, nausea, vomiting, fever up to 102.
mixing error occurred, patient may have received only diluent. patient was revaccinated 05/05
Patient presented to the vaccination site on 11/18/2021. The client notified PHN that he received a both doses of Sinovac COVID vaccine in different country on 3/28/2021 and 5/6/2021. PHN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Janssen. Per CDC guidance, approval to proceed with COVID vaccine Janssen was obtained from medical consult team via text message from PHN, Vaccine Operations Lead, per Dr. Client received COVID vaccine Janssen Lot#211D21A on 11/18/2021. The client did not report any symptoms during the 30 minute observation period. RN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 1530 walking with steady gai
3am severe chills with 104.6 fever; vomiting, diarrhea; severe headache, felt like pins and needles all over body. Fever 101 with Tylenol/ibuprofen alternating, lasted exactly 24 hours. Next 2 days severe head ache and tired; next 5 days swollen injection site- red and hurt; lymph node swollen under right arm about the size of a baseball; since this time have metallic taste and smell. This piece still happening
Patient became ill with severe headache,  shortness of breath, fatigue,  faint,  dizzy,  shaky hands,  nausea,  stomach pain.  we canceled family plans.  The connection to the vaccine did not occur to me.  Patient never fully recovered and the symptoms continued.  A few months later she was hearing voices and seeing shadows and prescribed anti psychotic med.  Months later she was self harming.  She was evaluated and diagnosed with autism although it had been ruled out 3 years earlier.  Then  attempted to end her life by overdosing on pills.  Patient spent the following 18 months in treatment for mental health.  upon returning to home on July 31, 2023, I immediately noticed her symptoms had worsened and she more ill.  Her pediatrician administered tests ruling out Mono, Celiac, Thyroid and Anemia.  Pediatrician referred patient to Hospital GI, Neurology and Cardiology  where she was diagnosed with dysautonomia.  It was suggested that it was very likely she has POTS and referred to the POTS clinic with a 5 month wait.  She was tested for Lyme disease with her pediatrician looking for antibodies in the blood stream.   And,  DNA Connexions lab separately which which tested positive for 4 confections of Lyme disease.
Chest pain radiating to arm pits, shortness of breath, fast heart rate, fainting, loss of vision
Patient developed shingles 8 days after receiving both influenza vaccine( Unknown which flu vaccine) IM and Pfizer COVID vaccine dose #3. She has flank pain, itching, and vescular rash to left flank. She has been rx valtrex and gabapentin.
Syncope or near syncopal episode, patient was at school, felt lightheaded and passed out during a chorus practice.   He immediately woke up, felt weak and was sent home.
numbness over 60%; Information has been received from a other health professional, referring to a currently 29 years old female patient. The patient's medical history included asthma, depression, high cholesterol, liver disease, paraesthesia and fatigue. The current condition included multiple sclerosis. Information of concomitant therapy was not provided.   On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dose, strength, route, lot# and expiration date were unknown) for prophylaxis.         On an unknown date, the patient experienced numbness over 60%. The outcome of the event was unknown. The relationship between suspect therapy and the event was not reported.
Covid monitoring documentation. PT admitted 12/10/21 documented to have positive covid. PT received Janssen 3/23/21 Lot 1808978 for dose 1.
He was recently discharge a few days ago after being treated for covid pneumonia. During this admission, he was noted to have pneumomediastinum and pneumothorax. He reported that after discharge, he continue to be short of breath worse with exertion. He has cough with minimal sputum . He has undocumented fever. AT ER, CTchest suggestive with pneumonia. He was admitted. He was treated with decadron and remdesivir in last admission
pt became limp followed by involuntary movements to all extremities w/pallor;W/D to touch;resp regular @ 18;BP 84/50;involuntary movement lasting approx 1-2sec afterwards;
Herpes zoster diagnosis in a 2-dose varicella vaccine recipient. Unilateral rash in one dermatome, no pain reported. No history of varicella. Prescribed acyclovir.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's concurrent conditions and medical history were not reported. Approximately in 2015 (reported as in past six months), the patient was vaccinated with ZOSTAVAX (unknown route and dose) lot # L028280 and expiry date of 28-OCT-2015 in left arm. Concomitant medications were not reported. The patient had come to pharmacy to complain of injection site adverse events post vaccination with ZOSTAVAX. The patient developed cellulitis like reaction of left arm that traveled from the injection site down the whole left arm. The patient was seen by her physician and treated with antibiotics. The outcome of the events was resolve don an unknown date in 2015. Causality assessment was not reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Case number PHEH2014US022846 is an initial spontaneous report received from a nurse on 11 Nov 2014. This report refers to an eight year old female patient. Her past medical history and concomitant medications were not reported. On 11 Nov 2014, she was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly after the nurse aspirated the pre-filled syringe (drug administration error). The reporter stated that there was no blood prior to the administration. There was no blood at the site of injection or on the needle but there was some blood in the syringe. The patient reported minor discomfort at the vaccination site. The outcome of the event was not reported. The seriousness and causality of the event was not reported.
Red, oblong rash on arm.  Rash aprox. six inches long, three inches wide. Rash itches and painful to touch.
COVID-19; COVID-19; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (Not Provided). The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 2021 (Batch/Lot number: unknown) at the age of 62 years as dose 3 (booster), single, intramuscular, administration date 2020 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administration date 2020 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for colitis ulcerative. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2020, outcome "recovered" and all described as "COVID-19". Patient reported events of non-serious COVID and bad reaction to the Booster vaccine shot with HUMIRA (ADALIMUMAB). There was no reported medical history. In 2020, the patient experienced COVID. In 2021, the patient experienced bad reaction to the booster vaccine shot and covid. PFIZER BIONTECH COVID-19 VACCINE (TOZINAMERAN) was also considered suspect. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter considered event COVID-19 causality not reported for bnt162b2 and Humira, and event Vaccination adverse reaction/ Vaccination complication causality Possible for bnt162b2 and not reported for Humira. The action taken for adalimumab was unknown.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on temporal association, there is reasonable possibility of causal association between the Reported events and the suspect drug BNT162B2.  The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
CONFUSION, POSITIVE COVID TEST, BILATERAL PULMONARY INFILTRATE, PULMONARY EDEMA
The Patient received the Pfizer booster shot earlier than the due date time. He received his second dose on October the 7th, 2021, and gotten his booster shot on December 29th,2021. The patient didn't have any reactions to the vaccination in the observation room.
Moderate discomfort; but, very annoying. Used a pain relief cream, at times, especially before bed. Rash got bigger and bigger. It is now the size, slightly larger than a silver dollar.
I went to bed that night 6 hours after vaccine,  and woke up with extreme flu 8 and half hours after vaccine. High fever chills, vomiting, body aches. The next morning  15 hours after vaccine my arm started to hurt so badly I could barely move. The nerves in the injected arm running up and down with shooting and  pulsing, lack of feeling in hands and extreme pain through the the arm and shoulder on the injected side.  The pain was extreme for 13 days I lost work time. I saw several doctors who sent me on my way. My arm still hurts right now 24 days since vaccine. The pain is not extreme but the nerves still shoot pain and oils and there is often extreme pain by the end of the day.